Stock data
NextCure, Inc. (NXTC)
NextCure, Inc. (NXTC) reported net income of -US$55.84M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$57.62M | -US$55.84M | — |
| 2024 | — | — | -US$59.75M | -US$55.65M | — |
| 2023 | — | — | -US$67.64M | -US$62.72M | — |
| 2022 | — | — | -US$75.91M | -US$74.73M | — |
| 2021 | — | — | -US$70.77M | -US$69.39M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$14.89M | — |
| 2026-03-31 | — | -US$9.80M | — |
| 2025-12-31 | — | -US$9.44M | — |
| 2025-09-30 | — | -US$8.62M | — |
| 2025-06-30 | — | -US$26.81M | — |
| 2025-03-31 | — | -US$10.98M | — |
| 2024-12-31 | — | -US$11.60M | — |
| 2024-09-30 | — | -US$11.54M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.